Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 21, 2010, Pages 9843-9848

  Sui, Yongjun ^a   Zhu, Qing ^a   Gagnon, Susan ^a   Dzutsev, Amiran ^a   Terabe, Masaki ^a   Vaccari, Monica ^a   Venzon, David ^a   Klinman, Dennis ^b   Strober, Warren ^a   Kelsall, Brian ^a   Franchini, Genoveffa ^a   Belyakov, Igor M ^a,c   Berzofsky, Jay A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c MIDWEST RESEARCH INSTITUTE   (United States)

Author keywords

APOBEC3G; HIV vaccine; IL 15; Polyfunctional T cells; Toll like receptor agonist

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 15; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; TOLL LIKE RECEPTOR AGONIST;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; DRUG MECHANISM; DRUG POTENTIATION; INNATE IMMUNITY; MACACA; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTECTION; SIMIAN IMMUNODEFICIENCY VIRUS; UPREGULATION; VIRUS IMMUNITY; VIRUS LOAD;

ADAPTIVE IMMUNITY; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTIDINE DEAMINASE; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTERLEUKIN-15; MACACA MULATTA; MUCOUS MEMBRANE; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

ANIMALIA; MACACA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 77953118149     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911932107     Document Type: Article

References (43)

1. Lackner AA, Mohan M, Veazey RS (2009) The gastrointestinal tract and AIDS pathogenesis. Gastroenterology 136:1965-1978.
2. Zhang Z-Q, et al. (1999) Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286:1353-1357.
3. Brenchley JM, et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200:749-759.
4. Belyakov IM, et al. (2001) Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med 7:1320-1326.
5. Belyakov IM, et al. (2006) Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa. Blood 107:3258-3264.
6. Wille-Reece U, et al. (2006) Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J Exp Med 203:1249-1258.
7. Kwissa M, et al. (2007) Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus. J Exp Med 204:2733-2746.
8. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-995.
9. Zhu Q, et al. (2008) Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines. Proc Natl Acad Sci USA 05:16260-16265.
10. Zhu Q, et al. (2010) Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J Clin Invest 120:607-616.
11. Oh S, Perera LP, Burke DS, Waldmann TA, Berzofsky JA (2004) IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells. Proc Natl Acad Sci USA 101:15154-15159.
12. Oh S, et al. (2008) IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis. Proc Natl Acad Sci USA 105:5201-5206.
13. Boyer JD, et al. (2007) Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc Natl Acad Sci USA 104:18648-18653.
14. Kutzler MA, et al. (2005) Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol 175:112-123.
15. Harris RS, et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809.
16. Chiu YL, et al. (2005) Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435:108-114.
17. Jin X, et al. (2005) APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia. J Virol 79:11513-11516.
18. Biasin M, et al. (2007) Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals. J Infect Dis 195:960-964.
19. Wang Y, et al. (2009) Mucosal immunization in macaques upregulates the innate APOBEC 3G anti-viral factor in CD4(+) memory T cells. Vaccine 27:870-881.
20. Trapp S, et al. (2009) Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G. J Virol 83:884-895.
21. Dzuris JL, et al. (2001) Molecular determinants of peptide binding to two common Rhesus macaque major histocompatibility complex class II molecules. J Virol 75: 10958-10968.
22. Vaccari M, et al. (2008) Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency. J Virol 82:9629-9638.
23. Patterson LJ, et al. (2004) Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting. J Virol 78:2212-2221.
24. Cecchinato V, et al. (2008) Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol 180:5439-5447.
25. Rosati M, et al. (2005) DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J Virol 79:8480-8492.
26. Rosati M, et al. (2009) DNA vaccination in Rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge. Proc Natl Acad Sci USA 106:15831-15836.
27. Liu J, et al. (2009) Immune control of an SIV challenge by a T-cell-based vaccine in Rhesus monkeys. Nature 457:87-91.
28. Yant LJ, et al. (2006) The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol 80:5074-5077.
29. Abel K, et al. (2001) Anatomic site and immune function correlate with relative cytokine mRNA expression levels in lymphoid tissues of normal Rhesus macaques. Cytokine 16:191-204.
30. Mandl JN, et al. (2008) Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 4:1077-1087.
31. Koning FA, et al. (2009) Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol 83:9474-9485.
32. Kreisberg JF, Yonemoto W, Greene WC (2006) Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J Exp Med 203:865-870.
33. Pion M, et al. (2006) APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J Exp Med 203:2887-2893.
34. Stopak KS, Chiu YL, Kropp J, Grant RM, Greene WC (2007) Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J Biol Chem 282:3539-3546.
35. Waldmann TA (2006) The biology of interleukin-2 and interleukin-15: Implications for cancer therapy and vaccine design. Nat Rev Immunol 6:595-601.
36. Belyakov IM, Isakov DV, Zhu Q, Dzutsev AH, Berzofsky JA (2007) A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against SHIV viral depletion of mucosal CD4+ T cells. J Immunol 178:7211-7221. (Pubitemid 46847447)
37. Kiepiela P, et al. (2007) CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13:46-53.
38. Schellens IM, et al. (2008) Abundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time. PLoS ONE 3:e2745.
39. McDermott AB, et al. (2005) Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive Rhesus macaques. J Virol 9:15556-15566.
40. McElrath MJ, et al.; Step Study Protocol Team (2008) HIV-1 vaccine-induced immunity in the test-of-concept Step Study: A case-cohort analysis. Lancet 372:1894-1905.
41. Pido-Lopez J, et al. (2007) Stimulation of cell surface CCR5 and CD40 molecules by their ligands or by HSP70 up-regulates APOBEC3G expression in CD4(+) T cells and dendritic cells. J Immunol 178:1671-1679. (Pubitemid 46154639)
42. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH (2006) T cell- and B cellindependent adaptive immunity mediated by natural killer cells. Nat Immunol 7:507-516.
43. Lamoreaux L, Roederer M, Koup R (2006) Intracellular cytokine optimization and standard operating procedure. Nat Protoc 1:1507-1516.